Abbott Laboratories (ABT)
Market Closed
12 Jun, 20:00
$
136. 45
+1.17
+0.86%
$
235.37B Market Cap
36.49 P/E Ratio
2.2% Div Yield
5,082,400 Volume
4.44 Eps
$ 135.28
Previous Close Day Range
135.46 136.89
Year Range
99.71 141.23
Earnings results expected in 33 days
Summary
ABT closed today higher at $136.45, an increase of 0.86% from yesterday's close, completing a monthly increase of 5.37% or $6.95. Over the past 12 months, ABT stock gained 20.02%.
ABT pays dividends to its shareholders, with the most recent payment made on May 15, 2025. The next estimated payment will be in In 2 months on Aug 15, 2025 for a total of $0.59.
The last earnings report, released on Apr 15, 2025, exceeded the consensus estimates by 0%. On average, the company has surpassed earnings expectations by 0%, based on the last three reports. The next scheduled earnings report is due on Jul 16, 2025.
Abbott Laboratories has completed 8 stock splits, with the recent split occurring on Jan 02, 2013.
The company's stock is traded on 15 different exchanges and in various currencies, with the primary listing on NYSE (USD).
Want to track ABT and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
ABT Chart
5 Unstoppable Dividend Stocks to Buy If There's a Stock Market Sell-Off
Volatility is a part of life for long-term investors. The reasons the market goes up or down change, but the constant is that high-quality stocks, businesses that increasingly make more money over time, will reward investors if you wait long enough.
Fool | 1 day ago
Is Abbott (ABT) a Buy as Wall Street Analysts Look Optimistic?
The recommendations of Wall Street analysts are often relied on by investors when deciding whether to buy, sell, or hold a stock. Media reports about these brokerage-firm-employed (or sell-side) analysts changing their ratings often affect a stock's price.
Zacks | 1 week ago
Abbott (ABT) Stock Drops Despite Market Gains: Important Facts to Note
Abbott (ABT) closed at $132.96 in the latest trading session, marking a -0.56% move from the prior day.
Zacks | 1 week ago
Abbott Laboratories Dividends
| ABT In 1 month Estimated | Quarterly | $0.59 Per Share |
| ABT 1 month ago Paid | Quarterly | $0.59 Per Share |
| ABT 4 months ago Paid | Quarterly | $0.59 Per Share |
| ABT 7 months ago Paid | Quarterly | $0.55 Per Share |
| ABT 10 months ago Paid | Quarterly | $0.55 Per Share |
| ABT 12 Apr 2024 Paid | Quarterly | $0.55 Per Share |
Abbott Laboratories Earnings
| 16 Jul 2025 (33 Days) Date | | - Cons. EPS | - EPS |
| 15 Apr 2025 Date | | - Cons. EPS | - EPS |
| 22 Jan 2025 Date | | 1.34 Cons. EPS | 1.34 EPS |
| 16 Oct 2024 Date | | 1.2 Cons. EPS | 1.21 EPS |
| 18 Jul 2024 Date | | 1.1 Cons. EPS | 1.14 EPS |
| ABT In 1 month Estimated | Quarterly | $0.59 Per Share |
| ABT 1 month ago Paid | Quarterly | $0.59 Per Share |
| ABT 4 months ago Paid | Quarterly | $0.59 Per Share |
| ABT 7 months ago Paid | Quarterly | $0.55 Per Share |
| ABT 10 months ago Paid | Quarterly | $0.55 Per Share |
| ABT 12 Apr 2024 Paid | Quarterly | $0.55 Per Share |
| 16 Jul 2025 (33 Days) Date | | - Cons. EPS | - EPS |
| 15 Apr 2025 Date | | - Cons. EPS | - EPS |
| 22 Jan 2025 Date | | 1.34 Cons. EPS | 1.34 EPS |
| 16 Oct 2024 Date | | 1.2 Cons. EPS | 1.21 EPS |
| 18 Jul 2024 Date | | 1.1 Cons. EPS | 1.14 EPS |
Abbott Laboratories (ABT) FAQ
What is the stock price today?
The current price is $136.45.
On which exchange is it traded?
Abbott Laboratories is listed on NYSE.
What is its stock symbol?
The ticker symbol is ABT.
Does it pay dividends? What is the current yield?
It does not pay dividends to its shareholders.
What is its market cap?
As of today, the market cap is 235.37B.
What is the earnings per share?
The EPS is 0.
When is the next earnings date?
The next earnings report will release on Jul 16, 2025.
Has Abbott Laboratories ever had a stock split?
Abbott Laboratories had 8 splits and the recent split was on Jan 02, 2013.
Abbott Laboratories Profile
| Medical - Devices Industry | Healthcare Sector | Mr. Robert B. Ford CEO | NYSE Exchange | 002824100 Cusip |
| US Country | 114,000 Employees | 15 Apr 2025 Last Dividend | 2 Jan 2013 Last Split | 13 Jan 1978 IPO Date |
Overview
Abbott Laboratories is a global healthcare company that engages in the discovery, development, manufacturing, and sale of a wide range of health care products. With its foundation laid in 1888, and headquartered in North Chicago, Illinois, the company has established a significant presence worldwide. Abbott operates across four main sectors: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices, catering to a diverse range of healthcare needs from generic pharmaceuticals to advanced medical devices.
Products and Services
Abbott Laboratories offers a comprehensive portfolio of products and services across various healthcare domains:
- Generic Pharmaceuticals: Includes treatments for pancreatic exocrine insufficiency, irritable bowel syndrome, biliary spasm, intrahepatic cholestasis, depressive symptoms, gynecological disorder, hormone replacement therapy, dyslipidemia, hypertension, hypothyroidism, Ménière's disease, vestibular vertigo, pain, fever, inflammation, migraine, anti-infective clarithromycin, influenza vaccine, and colon rhythm regulation products.
- Diagnostic Products: Offers laboratory and transfusion medicine systems in areas such as immunoassay, clinical chemistry, hematology, and transfusion. Includes molecular diagnostics for DNA and RNA processing and detection of infectious agents, point-of-care systems, blood gas testing cartridges, rapid diagnostics, molecular point-of-care testing for several diseases, cardiometabolic tests, drug and alcohol tests, remote patient monitoring, consumer self-tests, and laboratory automation and informatics solutions.
- Nutritional Products: Provides nutritional products for both pediatric and adult use, catering to the specific dietary needs of different age groups and health conditions.
- Medical Devices: Offers a wide array of devices for the treatment of cardiovascular diseases, including rhythm management, electrophysiology, heart failure, vascular, and structural heart devices. Additionally, the company develops diabetes care products such as blood glucose monitoring systems, along with neuromodulation devices for managing chronic pain and movement disorders.
Contact Information
Address: 100 Abbott Park Road
Phone: 224 667 6100
Website: https://www.abbott.com
2025 © Marketlog. All Rights Reserved.
